Attached files

file filename
EX-32.1 - CERTIFICATION - GREEN VISION BIOTECHNOLOGY CORP.gvbi_ex321.htm
EX-31.1 - CERTIFICATION - GREEN VISION BIOTECHNOLOGY CORP.gvbi_ex311.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-K

 

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended January 31, 2017

 

 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ----------------- to -----------------

 

Commission File No. 000-55210

 

GREEN VISION BIOTECHNOLOGY CORP

(Exact name of small business registrant as specified in its charter)

 

Nevada

 

7380

 

98-1060941

(State or Other Jurisdiction of
Incorporation or Organization)

 

 (Primary Standard Industrial
Classification Number)

 

 (IRS Employer

Identification Number)

 

1255 W. Rio Salado Parkway

Suite 215

Tempe, AZ 85281

(Address and telephone number of principal executive offices)

 

VIBE WIRELESS CORP

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant as required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. Yes o No x

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer

o

Accelerated filer

o

Non-accelerated filer

o

Smaller reporting company

x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act) Yes x No o

 

No market value has been computed as of July 31, 2016 based upon the fact that no active trading market has been established.

 

As of April 27, 2017, the Company had 60,790,000 shares of Common Stock outstanding.

 

 
 
 
 

 

TABLE OF CONTENTS

 

PART 1

ITEM 1

Description of Business

 

3

 

ITEM 1A

Risk Factors

 

4

 

ITEM 2

Description of Property

 

4

 

ITEM 3

Legal Proceedings

 

4

 

ITEM 4

Mine Safety Disclosures

 

4

 

 

 

 

 

 

PART II

ITEM 5

Market for Common Equity and Related Stockholder Matters

 

5

 

ITEM 6

Selected Financial Data

 

6

 

ITEM 7 

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

6

 

ITEM 7A

Quantitative and Qualitative Disclosures about Market Risk

 

7

 

ITEM 8

Financial Statements and Supplementary Data

 

8

 

ITEM 9

Changes In and Disagreements with Accountants on Accounting and Financial Disclosure

 

19

 

ITEM 9A (T)

Controls and Procedures

 

19

 

 

 

 

 

 

PART III

ITEM 10

Directors, Executive Officers, Promoters and Control Persons of the Company

 

21

 

ITEM 11

Executive Compensation

 

23

 

ITEM 12

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

23

 

ITEM 13

Certain Relationships and Related Transactions

 

24

 

ITEM 14

Principal Accountant Fees and Services

 

24

 

 

 

 

 

 

PART IV

ITEM 15

Exhibits

 

25

 

 

 
2
 
 

 

PART I

 

Item 1. Description of Business

 

FORWARD-LOOKING STATEMENTS

 

This annual report contains forward-looking statements. These statements relate to future events or our future financial performance. These statements often can be identified by the use of terms such as "may," "will," "expect," "believe," "anticipate," "estimate," "approximate" or "continue," or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management's best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

 

GENERAL

 

Green Vision Biotechnology Corp. (the “Company”), formerly known as Vibe Wireless Corp., formerly known as Any Translation Corp., was incorporated under the laws of the State of Nevada on July 5, 2012. We were founded to be in the business of translation and interpretation. The Company undertook translation and interpretation projects for various fields from business, economics, to science issues. All operating projects were customer tailored with freelancers that operated in their mother-tongue. The Company later adopted a business plan to pursue business opportunities in the global telecommunications industry. We are presently in the process of exploring other business opportunities.

 

On November 12, 2015, we changed our name to Vibe Wireless Corp in connection with merging with our wholly-owned subsidiary. This name change and our ticker symbol change was acknowledged by FINRA and effected in the market on November 23, 2015.

 

On September 30, 2016, the Company filed a Certificate of Amendment with the Nevada Secretary of State (the “Nevada SOS”) whereby it amended its Articles of Incorporation by increasing the Company’s authorized number of shares of common stock from 75 million to 750 million and increasing all of its issued and outstanding shares of common stock at a ratio of ten (10) shares for every one (1) share held. The Company’s Board of Directors approved this amendment on September 30, 2016. This stock split has been retroactively applied.

 

On September 30, 2016, the Company filed Articles of Merger with the Nevada SOS whereby it entered into a statutory merger with its wholly-owned subsidiary, Green Vision Biotechnology Corp. pursuant to Nevada Revised Statutes 92A.200 et. seq. The effect of such merger is that the Company is the sole surviving entity and changed its name to “Green Vision Biotechnology Corp.”

 

On September 30, 2016, the Company filed an Issuer Company-Related Action Notification Form with FINRA requesting that the aforementioned forward split and name change be effected in the market. The Company also requested that its ticker symbol be changed to “GVBT”. Such notification form is being reviewed by FINRA. This name change and our ticker symbol change was acknowledged by FINRA and effected in the market on November 27, 2016.

 

 
3
 
Table of Contents

 

Employees

 

We have no employees as of the date of this annual report, other than our sole officer and director. If our officer and director should resign or die, we will not have a chief executive officer. This could result in our operations suspending until we find another CEO or our investors might lose their money. Since we do not possess a personal life insurance on our existing CEO and we do not have a contract for his services, the investors will have a great chance of losing their investment in the event of us losing our CEO.

 

Item 1A. Risk Factors

 

Not applicable to smaller reporting companies, such as our company.

 

Item 2. Description of Property

 

We do not own any real estate or other properties.

 

Item 3. Legal Proceedings

 

We know of no legal proceedings to which we are a party or to which any of our property is the subject which are pending, threatened or contemplated or any unsatisfied judgments against us.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

 
4
 
Table of Contents

 

PART II

 

Item 5. Market for Common Equity and Related Stockholder Matters

 

Market Information

 

There is a limited public market for our common shares. Our common shares are not quoted on the OTC Bulletin Board at this time. Trading in stocks quoted on the OTC Bulletin Board is often thin and is characterized by wide fluctuations in trading prices due to many factors that may be unrelated to a company’s operations or business prospects. We cannot assure you that there will be a market in the future for our common stock.

 

OTC Bulletin Board securities are not listed or traded on the floor of an organized national or regional stock exchange. Instead, OTC Bulletin Board securities transactions are conducted through a telephone and computer network connecting dealers in stocks. OTC Bulletin Board issuers are traditionally smaller companies that do not meet the financial and other listing requirements of a regional or national stock exchange.

 

As of January 31, 2017, no shares of our common stock have traded on an exchange or on the OTC Marketplace.

 

Number of Holders

 

As of April 27, 2017, 60,790,000 issued and outstanding shares of common stock were held by a total of 8 shareholders of record.

 

Dividends

 

No cash dividends were paid on our shares of common stock during the fiscal years ended January 31, 2017 and 2016. We have not paid any cash dividends since our inception and do not foresee declaring any cash dividends on our common stock in the foreseeable future. 

 

Recent Sales of Unregistered Securities

 

None.

 

Purchase of our Equity Securities by the Company and any of our Officers and Directors

 

None.

 

Other Stockholder Matters

 

None.

 

 
5
 
Table of Contents

 

Item 6. Selected Financial Data

 

Not applicable.

 

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion should be read in conjunction with our financial statements, including the notes thereto, appearing elsewhere in this annual report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward looking statements. Our audited financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles.

 

Results of operations

 

We have incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation.

 

We expect we will require additional capital to meet our long term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

 

YEAR ENDED JANUARY 31, 2017 COMPARED TO YEAR ENDED JANUARY 31, 2016.

 

Our net loss for the years ended January 31, 2017 was $69,613 compared to a net loss of $37,560 for the year ended January 31, 2016. During the years ended January 31, 2017 and 2016, we generated revenues of $0 and $0.

 

During the year ended January 31, 2017, we incurred general expenses of $69,613 compared to $37,560 for the year ended January 31, 2016. The increase in general expenses is primarily due to increase in professional fees during the year ended January 31, 2017.

 

 LIQUIDITY AND CAPITAL RESOURCES

 

 FISCAL YEARS ENDED JANUARY 31, 2017 AND 2016

 

As of January 31, 2017, our total assets were $ 0 and our total liabilities were $106,648 comprised of advances from a related party, advances from a non-related party, accrued interest, and accounts payable.

 

 
6
 
Table of Contents

 

As of January 31, 2016, our total assets were $0 and our total liabilities were $37,035 comprised of advances from a related party and accounts payable and accrued expenses.

 

Stockholders’ deficit increased from a deficit of $37,035 as of January 31, 2016 to $106,648 as of January 31, 2017.

 

Cash Flows from Operating Activities

 

We have not generated positive cash flows from operating activities. For the year ended January 31, 2017, net cash flows used in operating activities were $64,940. For the year ended January 31, 2016, net cash flows used in operating activities was $35,289.

 

Cash Flows from Financing Activities

 

We have financed our operations primarily from either advances and loans from related parties and third parties or the issuance of equity instruments. For the fiscal year ended January 31, 2017, net cash from financing activities was $64,940 consisting entirely of advances and loans from a related party and a non-related party. For the fiscal year ended January 31, 2016, net cash from financing activities was $35,114 consisting of proceeds in advances from a related party and a director.

 

MATERIAL COMMITMENTS

 

As of the date of this Annual Report, we do not have any material commitments.

 

PURCHASE OF SIGNIFICANT EQUIPMENT

 

We do not intend to purchase any significant equipment during the next twelve months.

 

OFF-BALANCE SHEET ARRANGEMENTS

 

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

 

Not applicable to smaller reporting companies.

 

 
7
 
Table of Contents

 

Item 8. Financial Statements and Supplementary Data

 

INDEX TO FINANCIAL STATEMENTS

 

GREEN VISION BIOTECHNOLOGY CORP.

 

TABLE OF CONTENTS

JANUARY 31, 2017

 

* Report of Independent Registered Public Accounting Firm

 

9

 

 

 

 

 

* Balance Sheets as of January 31, 2017 and 2016.

 

10

 

 

 

 

 

* Statements of Operations for the years ended January 31, 2017 and 2016.

 

11

 

 

 

 

 

* Statements of Stockholders’ Equity (Deficit) as of January 31, 2017 and 2016.

 

12

 

 

 

 

 

* Statements of Cash Flows for the years ended January 31, 2017 and 2016.

 

13

 

 

 

 

 

* Notes to the Financial Statements

 

14 - 18

 

 

 
8
 
 

 

LBB & ASSOCIATES LTD., LLP

10260 Westheimer Road, Suite 310

Houston, TX 77042

Phone: (713) 800-4343 Fax: (713) 456-2408

 

Report of Independent Registered Public Accounting Firm

 

To the Board of Directors of

Green Vision Biotechnology Corp.

Tempe, Arizona

 

We have audited the accompanying balance sheets of Green Vision Biotechnology Corp., (the “Company”) as of January 31, 2017 and 2016 and the related statements of operations, stockholders' equity (deficit), and cash flows for each of the years in the two-year period ended January 31, 2017. Green Vision Biotechnology Corp.’s management is responsible for these financial statements. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Green Vision Biotechnology Corp., as of January 31, 2017 and 2016 and the results of its operations and its cash flows for each of the years in the two-year period ended January 31, 2017 in conformity with accounting principles generally accepted in the United States of America.

 

As discussed in Note 8 to the financial statements, the Company's absence of significant revenues, recurring losses from operations, and its need for additional financing in order to fund its projected loss in 2018 raise substantial doubt about its ability to continue as a going concern. The 2017 financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

/s/ LBB & Asscoiates Ltd., LLP 

LBB & Associates Ltd., LLP

Houston, Texas

April 28, 2017

 

 
9
 
Table of Contents

 

GREEN VISION BIOTECHNOLOGY CORP.

BALANCE SHEETS

JANUARY 31, 2017 AND 2016

 

 

 

2017

 

 

2016

 

ASSETS

Current Assets

 

 

 

 

 

 

Cash and cash equivalents

 

$ -

 

 

$ -

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$ -

 

 

$ -

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

Liabilities

 

 

 

 

 

 

 

 

Accounts Payable and accrued expenses

 

$ 6,944

 

 

$ 2,271

 

Note payable

 

 

49,704

 

 

 

-

 

Advances and loans from related party

 

 

50,000

 

 

 

34,764

 

Total current liabilities

 

 

106,648

 

 

 

37,035

 

Total Liabilities

 

 

106,648

 

 

 

37,035

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity (Deficit)

 

 

 

 

 

 

 

 

Common stock, par value $0.001; 750,000,000 shares authorized, 60,790,000 shares issued and outstanding

 

 

60,790

 

 

 

60,790

 

Additional paid in capital

 

 

(16,862 )

 

 

(16,862 )

Accumulated deficit

 

 

(150,576 )

 

 

(80,963 )

Total Stockholders’ Equity (Deficit)

 

 

(106,648 )

 

 

(37,035 )

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders’ Equity (Deficit)

 

$ -

 

 

$ -

 

 

See accompanying notes to financial statements.

 

 
10
 
Table of Contents

 

GREEN VISION BIOTECHNOLOGY CORP.

STATEMENTS OF OPERATIONS

FOR THE YEARS ENDED JANUARY 31, 2017 AND 2016

 

 

 

Year ended
January 31,
2017

 

 

Year ended
January 31,
2016

 

 

 

 

 

 

 

 

REVENUES

 

$ -

 

 

$ -

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

 

 

 

 

General expenses

 

 

69,613

 

 

 

37,560

 

TOTAL OPERATING EXPENSES

 

 

69,613

 

 

 

37,560

 

 

 

 

 

 

 

 

 

 

NET LOSS

 

$ (69,613 )

 

$ (37,560 )

 

 

 

 

 

 

 

 

 

NET LOSS PER SHARE: BASIC AND DILUTED

 

$ (0.00 )

 

$ (0.00 )

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED

 

 

60,790,000

 

 

 

60,790,000

 

 

See accompanying notes to financial statements

 

 
11
 
Table of Contents

 

GREEN VISION BIOTECHNOLOGY CORP.

STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

FOR THE YEARS ENDED JANUARY 31, 2017 AND 2016

 

 

 

Common Stock

 

 

Additional
Paid-in

 

 

Accumulated

 

 

Total
Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Equity (Deficit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, January 31, 2015

 

 

60,790,000

 

 

$ 60,790

 

 

$ (34,210 )

 

$ (43,403 )

 

$ (16,823 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Advances forgiven

 

 

 

 

 

 

 

 

 

 

17,348

 

 

 

 

 

 

 

17,348

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(37,560 )

 

 

(37,560 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, January 31, 2016

 

 

60,790,000

 

 

 

60,790

 

 

 

(16,862 )

 

 

(80,963 )

 

 

(37,035 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(69,613 )

 

 

(69,613 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance January 31, 2017

 

 

60,790,000

 

 

$ 60,790

 

 

$ (16,862 )

 

$ (150,576 )

 

$ (106,648 )

 

See accompanying notes to financial statements.

 

 
12
 
Table of Contents

 

GREEN VISION BIOTECHNOLOGY CORP.

STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED JANUARY 31, 2017 AND 2016

 

 

 

Year ended
January 31,
2017

 

 

Year ended
January 31,
2016

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss

 

$ (69,613 )

 

$ (37,560 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

 

4,673

 

 

 

2,271

 

Net Cash Used in Operating Activities

 

 

(64,940 )

 

 

(35,289 )

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Proceeds from note payable

 

 

49,704

 

 

 

-

 

Advances and loans from related party

 

 

15,236

 

 

 

35,114

 

Net Cash Provided by Financing Activities

 

 

64,940

 

 

 

35,114

 

 

 

 

 

 

 

 

 

 

Net Change in Cash

 

 

-

 

 

 

(175 )

Cash, beginning of period

 

 

-

 

 

 

175

 

Cash, end of period

 

$ -

 

 

$ -

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL CASH FLOW INFORMATION:

 

 

 

 

 

 

 

 

Interest paid

 

$ -

 

 

$ -

 

Income taxes paid

 

$ -

 

 

$ -

 

 

 

 

 

 

 

 

 

 

NONCASH TRANSACTIONS:

 

 

 

 

 

 

 

 

Advances forgiven

 

$ -

 

 

$ 17,348

 

 

See accompanying notes to financial statements.

 

 
13
 
Table of Contents

 

GREEN VISION BIOTECHNOLOGY CORP.

NOTES TO THE FINANCIAL STATEMENTS

JANUARY 31, 2017 and 2016

 

NOTE 1  ORGANIZATION AND NATURE OF BUSINESS

 

Green Vision Biotechnology Corp. (“we” or the “Company) was incorporated under the laws of the State of Nevada on July 5, 2012 as AnyTranslation Corp.

 

On September 2, 2015, a change in control of the Company took place by virtue of the Company's largest shareholder and sole officer and director at that time, selling 40,000,000 shares of the Company's common stock to Forestbay Capital Partners II, LLC, a Delaware limited liability company. Such shares represent 65.8% of the Company's total issued and outstanding shares of common stock. As part of the sale of the shares, Forestbay Capital Partners arranged with the former officer and director, prior to his resignation as the sole officer and director of the Company Board, to appoint Mr. Edward Mooney as the sole officer and director of the Company. Mr. Mooney is the Manager of Forestbay Capital Partners II, LLC.

 

On November 12, 2015, we changed our name to Vibe Wireless Corp in connection with merging with our wholly-owned subsidiary and adopted a business plan to pursue business opportunities in the global telecommunications industry. This name change and our ticker symbol change was acknowledged by FINRA and effected in the market on November 23, 2015. We are presently in the process of exploring business opportunities. 

 

On September 19, 2016, the Company's largest shareholder, Forest Bay Capital Partners II, LLC, a Delaware limited liability company, sold 50,000,000 shares of the Company's common stock to Ma Wai Kin. Such shares represent 82.25% of the Company's total issued and outstanding shares of common stock.

 

On September 30, 2016, Vibe Wireless Corp. (the "Company") filed a Certificate of Amendment with the Nevada Secretary of State (the “Nevada SOS”) whereby it amended its Articles of Incorporation by increasing the Company’s authorized number of shares of common stock from 75 million to 750 million and increasing all of its issued and outstanding shares of common stock at a ratio of ten (10) shares for every one (1) share held. The Company’s Board of Directors approved this amendment on September 30, 2016. This stock split has been retroactively applied.

 

On September 30, 2016, the Company filed Articles of Merger with the Nevada SOS whereby it entered into a statutory merger with its wholly-owned subsidiary, Green Vision Biotechnology Corp. pursuant to Nevada Revised Statutes 92A.200 et. seq. The effect of such merger is that the Company is the sole surviving entity and changed its name to “Green Vision Biotechnology Corp.”

 

On September 30, 2016, the Company filed an Issuer Company-Related Action Notification Form with FINRA requesting that the aforementioned forward split and name change be effected in the market. The Company also requested that its ticker symbol be changed to “GVBT”. Such notification form is being reviewed by FINRA. This name change and our ticker symbol change was acknowledged by FINRA and effected in the market on November 27, 2016.

 

 
14
 
Table of Contents

 

NOTE 2  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars.

 

Accounting Basis

The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (“GAAP” accounting). The Company has adopted a January 31 fiscal year end.

 

Cash and Cash Equivalents

The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company had $0 and $0 of cash as of January 31, 2017 and 2016, respectively.

 

Fair Value of Financial Instruments

The Company’s financial instruments consist of cash and cash equivalents, accrued expenses and amounts due to a shareholder. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements.

 

Income Taxes

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

 

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates

 

 
15
 
Table of Contents

 

Stock-Based Compensation

Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.

 

Basic Income (Loss) Per Share

Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of January 31, 2017 and 2016.

 

Recent Accounting Pronouncements

The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

 

NOTE 3  RELATED PARTY TRANSACTIONS

 

On June 29, 2015, a director forgave all his advances of $17,348 loaned to the Company. The advance forgiveness was recorded as additional capital during year ended January 31, 2016

 

On August 28, 2015, the Company’s new officer and director entered into an agreement to loan up to $50,000 to the Company, accruing interest at 8%, due on September 1, 2016, and unsecured. The maturity date has been extended by agreement to April 30, 2017. The balances as of January 31, 2017 and 2016 are $50,000 and $34,764, respectively.

 

NOTE 4 – NOTE PAYABLE

 

Beginning in September 2016, Hong Kong Prolific Mineral Resources Limited, a third party agreed to loan the Company funds on an on-going basis to be used for working capital accruing interest at 8%, due on January 31, 2018. The Company has received $49,704 in loans as of January 31, 2017.

 

NOTE 5  CAPITAL STOCK

 

The Company has 750,000,000, $0.001 par value shares of common stock authorized as a result of the amendment to its Articles of Incorporation in connection with the ten to one forward split of the Company's common stock.

 

No shares were issued during the year ended January 31, 2017 and 2016.

 

There were 60,790,000 and 60,790,000 shares of common stock issued and outstanding as of January 31, 2017 and 2016, respectively, as a result of a ten to one forward split of the Company's common stock.

 

 
16
 
Table of Contents

 

NOTE 6  COMMITMENTS AND CONTINGENCIES

 

The Company neither owns nor leases any real or personal property. An officer previously provided office services without charge. Such costs are immaterial to the financial statements and accordingly are not reflected herein. The officers and directors are involved in other business activities and most likely will become involved in other business activities in the future. When and if the Company commences operations or acquires another operating entity, at that time management will consider the need for a dedicated office.

 

NOTE 7  INCOME TAXES

 

As of January 31, 2017, the Company had net operating loss carry forwards of approximately $151,000 that may be available to reduce future years’ taxable income in varying amounts through 2033. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards.

 

The provision for Federal income tax consists of the following for the periods ended January 31:

 

 

 

2017

 

 

2016

 

Federal income tax benefit attributable to:

 

 

 

 

 

 

Current Operations

 

$ 23,668

 

 

$ 12,770

 

Less: valuation allowance

 

 

(23,668 )

 

 

(12,770 )

Net provision for Federal income taxes

 

$ -

 

 

$ -

 

 

The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows as of January 31:

 

 

 

2017

 

 

2016

 

Deferred tax asset attributable to:

 

 

 

 

 

 

Net operating loss carryover

 

$ 51,193

 

 

$ 27,525

 

Less: valuation allowance

 

 

(51,193 )

 

 

(27,525 )

Net deferred tax asset

 

$ -

 

 

$ -

 

 

Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards of approximately $151,000 for Federal income tax reporting purposes are subject to annual limitations. Changes in ownership could result in net operating loss carry forwards being limited as to use in future years.

 

 
17
 
Table of Contents

 

NOTE 8  GOING CONCERN

 

The accompanying financial statements have been prepared in conformity with generally accepted accounting principle, which contemplate continuation of the Company as a going concern. However, the Company had no revenues and accumulated deficit of $150,576 as of January 31, 2017. The Company currently has limited working capital, and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time.

 

Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses The Company intends to position itself so that it may be able to raise additional funds through the capital markets. In light of management’s efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

NOTE 9 –  SUBSEQUENT EVENTS

 

Subsequent to January 31, 2017 the Company received $22,500 in additional loans from Hong Kong Prolific Mineral Resources Limited pursuant to their agreement as mentioned in note 4.

 

 
18
 
Table of Contents

 

Item 9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosure

 

None.

 

Item 9A. Controls and Procedures

 

Managements Report on Disclosure Controls and Procedures

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)). The Company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, the Company conducted an evaluation of the effectiveness of the Company’s internal control over financial reporting as of January 31, 2017 using the criteria established in “ Internal Control - Integrated Framework ” issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO").

 

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of January 31, 2017, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.

 

1. We do not have an Audit Committee – While not being legally obligated to have an audit committee, it is the management’s view that such a committee, including a financial expert member, is an utmost important entity level control over the Company’s financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.

 

2. We did not maintain appropriate cash controls – As of January 31, 2017, the Company has not maintained sufficient internal controls over financial reporting for the cash process, including failure to segregate cash handling and accounting functions, and did not require dual signature on the Company’s bank accounts. Alternatively, the effects of poor cash controls were mitigated by the fact that the Company had limited transactions in their bank accounts.

 

 
19
 
Table of Contents

 

3. We did not implement appropriate information technology controls – As at January 31, 2017, the Company retains copies of all financial data and material agreements; however there is no formal procedure or evidence of normal backup of the Company’s data or off-site storage of data in the event of theft, misplacement, or loss due to unmitigated factors.

 

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

 

As a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control over financial reporting as of January 31, 2017 based on criteria established in Internal Control—Integrated Framework issued by COSO.

 

Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting identified in connection with our evaluation we conducted of the effectiveness of our internal control over financial reporting as of January 31, 2017, that occurred during our fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to temporary rules of the SEC that permit the Company to provide only management’s report in this annual report.

 

 
20
 
Table of Contents

 

PART III

 

Item 10. Directors, Executive Officers, Promoters and Control Persons of the Company

 

DIRECTORS AND EXECUTIVE OFFICERS

 

The name, address and position of our present officers and directors are set forth below:

 

Name and Address of Executive

Officer and/or Director

 

Age

 

Position

       

 

Edward P. Mooney

 

56

 

President, CEO, Secretary, Treasurer and Director

 

The following is a brief description of the business experience of our executive officers, director and significant employees:

 

Edward P. Mooney has acted as our President, CEO, Secretary, Treasurer and Director since September 2, 2015. On September 2, 2015, a change in control of the Company took place by virtue of the Company's largest shareholder and sole officer and director at that time, selling 40,000,000 shares of the Company's common stock to Forestbay Capital Partners II, LLC, a Delaware limited liability company. On September 19, 2016, Forest Bay Capital Partners, II, LLC, sold 50,000,000 shares of the Company’s stock to Ma Wai Kin resulting in a change in control.

 

Our president will be devoting approximately 25% of his business time to our operations. Once we expand operations, and are able to attract more customers to purchase our services, Mr. Mooney has agreed to commit more time as required. Because Mr. Mooney will only be devoting limited time to our operations, our operations may be sporadic and occur at times which are convenient to him. As a result, operations may be periodically interrupted or suspended which could result in a lack of revenues and a cessation of operations.

 

 
21
 
Table of Contents

 

Our Director’s Biographies

 

Edward Mooney

 

Mr. Mooney has 25 years of experience in all facets of corporate development for publicly traded companies and privately held ventures and investments including finance, mergers and acquisitions, corporate governance, investor relations, and regulatory compliance. He has served as a director of publicly-traded companies, including most recently as a director of American Sands Energy Corporation from April 2011 until August 2014 and Colombia Energy Resources from 2010 to April 2013. Both these companies were engaged in energy-related natural resources. He also has and presently serves as managing director of a number of privately-held companies investing in and developing products, services and products in the alternative energy and specialty agricultural chemical industries, including Forestbay Capital Partners II, LLC, for whom he has served as Manager since June 2014. Since August 2013, he has served as director, corporate secretary and executive vice president of Cobalt Holdings, Inc., a private company developing international telecommunications projects. Mr. Mooney received a Masters Degree in Education in 1990 and a Bachelors Degree in Geography in 1982, each from the California State University System.

 

COMMITTEES OF THE BOARD OF DIRECTORS

 

Our Board of Directors has no committees. We do not have a standing nominating, compensation or audit committee.

 

SIGNIFICANT EMPLOYEES

 

We have no employees. Our sole officer and director, Edward Mooney, is an independent contractor to us and currently devotes approximately twenty hours per week to company matters. After receiving funding pursuant to our business plan Mr. Mooney intends to devote as much time as the Board of Directors deems necessary to manage the affairs of the company.

 

 
22
 
Table of Contents

 

Item 11.

EXECUTIVE COMPENSATION

 

The following tables set forth certain information about compensation paid, earned or accrued for services by our President, and Secretary and all other executive officers (collectively, the “Named Executive Officers”) from inception on July 5, 2012 until January 31, 2017:

 

Summary Compensation Table

 

Name and 

Principal

Position

 

Year

 

Salary

($)

 

 

Bonus

($)

 

 

Stock

Awards

($)

 

 

Option

Awards

($)

 

 

Non-Equity

Incentive Plan

Compensation

($)

 

 

Nonqualified

Deferred

Compensation

($)

 

 

All Other

Compensation

($)

 

 

Total

($)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Edward P. Mooney, President, CEO, Secretary,
Treasurer

 

September 2, 2015 to January 31, 2017

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

There are no current employment agreements between the company and its officers.

 

CHANGE OF CONTROL

 

As of January 31, 2017, we had no pension plans or compensatory plans or other arrangements that provide compensation in the event of a termination of employment or a change in our control.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

 

The following table sets forth, as of April 27, 2017, the number and percentage of outstanding shares of our common stock beneficially owned by: (a) each person who is known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock; (b) each of our directors; (c) the Named Executive Officers (as defined in “Item 11. Executive Compensation”); and (d) all current directors and executive officers, as a group. As of April 27, 2017, there were 60,790,000 shares of common stock issued and outstanding. Other than our common stock, we have no other series of stock outstanding.

 

Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. Under this rule, certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire shares (for example, upon exercise of an option or warrant) within 60 days of the date as of which the information is provided.

 

 
23
 
Table of Contents

 

In computing the percentage ownership of any person, the amount of shares is deemed to include the amount of shares beneficially owned by such person by reason of such acquisition rights. As a result, the percentage of outstanding shares of any person as shown in the following table does not necessarily reflect the person’s actual voting power at any particular date.

 

To our knowledge, except as indicated in the footnotes to this table and pursuant to applicable community property laws, (a) the persons named in the table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them, subject to applicable community property laws; and (b) no person owns more than 5% of our common stock.

 

Name and Address of Beneficial Owner

 

Number of Shares Owned

 

 

Percentage of
Class

 

 

 

 

 

 

 

 

Ma Wai Kin

Victory Global Trustee Company Limited

Room 3502, Chun Lai House

Hang Chun Court, No.2

Fortune Street, Cheung Sha, Wan Kowloon, China

 

 

50,000,000

 

 

 

82.3 %

 

Changes in Control

 

On September 19, 2016, the Company's largest shareholder, Forest Bay Capital Partners II, LLC, a Delaware limited liability company, sold 50,000,000 shares of the Company's common stock to Ma Wai Kin. Such shares represent 82.25% of the Company's total issued and outstanding shares of common stock and that transaction resulted in a change in control of the Company.

 

Item 13. Certain Relationships and Related Transactions

 

During the year ended January 31, 2017, we had not entered into any transactions with our sole officer or director, or persons nominated for these positions, beneficial owners of 5% or more of our common stock, or family members of these persons wherein the amount involved in the transaction or a series of similar transactions exceeded the lesser of $120,000 or 1% of the average of our total assets for the last three fiscal years.

 

Item 14. Principal Accountant Fees and Services 

 

During fiscal year ended January 31, 2017, we paid approximately $10,000 in fees to our principal independent accountants for professional services rendered in connection with the audit of our fiscal year end financial statements and quarterly reviews.

 

 
24
 
Table of Contents

 

Item 15. Exhibits

 

The following exhibits are filed as part of this Annual Report.

 

Exhibits:

 

31.1 Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act

 

 

32.1 Certification of Chief Executive Officer and Chief Financial Officer Under Section 1350 as Adopted Pursuant Section 906 of the Sarbanes-Oxley Act

 

 

25

 
Table of Contents

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Signature

 

Title

 

Date

 

 

/s/ Edward P Mooney

President, CEO

May 1, 2017

Edward P Mooney

 

Treasurer, Secretary and Director

 

 

 

(Principal Executive Officer, Principal Accounting and Financial Officer)

 

 

 

 

26